Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Dec 2;64(4):606–611. doi: 10.1136/ard.2004.020784

Impact of musculoskeletal disorders on quality of life: an inception cohort study

C Roux 1, F Guillemin 1, S Boini 1, F Longuetaud 1, N Arnault 1, S Hercberg 1, S Briancon 1
PMCID: PMC1755431  PMID: 15576417

Abstract

Objective: To assess longitudinally the impact of new onset musculoskeletal (MSK) disorders on quality of life (QoL).

Methods: An inception cohort of 1202 subjects in France aged 45–60 years was determined to be free of MSK problems at baseline. Over 28 months of follow up between 1996 and 1998, 310 were diagnosed with MSK disorders and matched for age and sex with 620 healthy controls. The impact of the MSK disorder onset on QoL was assessed by the change in SF-36 dimension scores over time, using a linear mixed ANOVA model to compare the groups.

Results: The incidence of MSK disorder was 13.6% per person-year in the spine, 4.2% per person-year in a joint, and 4.6% per person-year at an extra-articular site. The greatest change in QoL was a 10 point drop in the 100 point SF-36 bodily pain dimension scale in the MSK group. Compared with controls, subjects with an MSK disorder had significantly greater reductions in the following dimensions: bodily pain (a –7.4 point difference in change), vitality (–2.7), general health (–1.8), and physical functioning (–1.3). Within the MSK group, chronic disorders had a greater impact than acute ones on the physical functioning (–2.1), role emotional (–8.4), and social functioning (–5.9) dimensions.

Conclusion: New onset MSK disorders have a marked deleterious effect on QoL in the physical domain, with lesser effects on social and mental functioning. This evidence of an early significant impact on their QoL reinforces recent recommendations for early treatment and primary prevention.

Full Text

The Full Text of this article is available as a PDF (85.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Badley E. M., Tennant A. Impact of disablement due to rheumatic disorders in a British population: estimates of severity and prevalence from the Calderdale Rheumatic Disablement Survey. Ann Rheum Dis. 1993 Jan;52(1):6–13. doi: 10.1136/ard.52.1.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Badley E. M. The economic burden of musculoskeletal disorders in Canada is similar to that for cancer, and may be higher. J Rheumatol. 1995 Feb;22(2):204–206. [PubMed] [Google Scholar]
  3. Biering-Sørensen F. Low back trouble in a general population of 30-, 40-, 50-, and 60-year-old men and women. Study design, representativeness and basic results. Dan Med Bull. 1982 Oct;29(6):289–299. [PubMed] [Google Scholar]
  4. Birrell F. N., Hassell A. B., Jones P. W., Dawes P. T. How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional study. Clin Rheumatol. 2000;19(3):195–199. doi: 10.1007/s100670050155. [DOI] [PubMed] [Google Scholar]
  5. Bombardier C., Ware J., Russell I. J., Larson M., Chalmers A., Read J. L. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. Am J Med. 1986 Oct;81(4):565–578. doi: 10.1016/0002-9343(86)90539-5. [DOI] [PubMed] [Google Scholar]
  6. Brazier John, Roberts Jennifer, Deverill Mark. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002 Mar;21(2):271–292. doi: 10.1016/s0167-6296(01)00130-8. [DOI] [PubMed] [Google Scholar]
  7. Cunningham L. S., Kelsey J. L. Epidemiology of musculoskeletal impairments and associated disability. Am J Public Health. 1984 Jun;74(6):574–579. doi: 10.2105/ajph.74.6.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ethgen Olivier, Kahler Kristijan H., Kong Sheldon X., Reginster Jean-Yves, Wolfe Frederick. The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis. J Rheumatol. 2002 Jun;29(6):1147–1155. [PubMed] [Google Scholar]
  9. Glazier R., Fry J., Badley E. Arthritis and rheumatism are neglected health priorities: a bibliometric study. J Rheumatol. 2001 Apr;28(4):706–711. [PubMed] [Google Scholar]
  10. Hagen K. B., Kvien T. K., Bjørndal A. Musculoskeletal pain and quality of life in patients with noninflammatory joint pain compared to rheumatoid arthritis: a population survey. J Rheumatol. 1997 Sep;24(9):1703–1709. [PubMed] [Google Scholar]
  11. Hercberg S., Preziosi P., Briançon S., Galan P., Triol I., Malvy D., Roussel A. M., Favier A. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamines et Minéraux AntioXydants. Control Clin Trials. 1998 Aug;19(4):336–351. doi: 10.1016/s0197-2456(98)00015-4. [DOI] [PubMed] [Google Scholar]
  12. Hill C. L., Parsons J., Taylor A., Leach G. Health related quality of life in a population sample with arthritis. J Rheumatol. 1999 Sep;26(9):2029–2035. [PubMed] [Google Scholar]
  13. Leplège A., Ecosse E., Verdier A., Perneger T. V. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998 Nov;51(11):1013–1023. doi: 10.1016/s0895-4356(98)00093-6. [DOI] [PubMed] [Google Scholar]
  14. Picavet H. S. J., Hazes J. M. W. Prevalence of self reported musculoskeletal diseases is high. Ann Rheum Dis. 2003 Jul;62(7):644–650. doi: 10.1136/ard.62.7.644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Picavet H. S. J., Hoeymans N. Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study. Ann Rheum Dis. 2004 Jun;63(6):723–729. doi: 10.1136/ard.2003.010769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Reynolds D. L., Chambers L. W., Badley E. M., Bennett K. J., Goldsmith C. H., Jamieson E., Torrance G. W., Tugwell P. Physical disability among Canadians reporting musculoskeletal diseases. J Rheumatol. 1992 Jul;19(7):1020–1030. [PubMed] [Google Scholar]
  17. Schlenk E. A., Erlen J. A., Dunbar-Jacob J., McDowell J., Engberg S., Sereika S. M., Rohay J. M., Bernier M. J. Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36. Qual Life Res. 1998 Jan;7(1):57–65. doi: 10.1023/a:1008836922089. [DOI] [PubMed] [Google Scholar]
  18. Scott D. L., Garrood T. Quality of life measures: use and abuse. Baillieres Best Pract Res Clin Rheumatol. 2000 Dec;14(4):663–687. doi: 10.1053/berh.2000.0106. [DOI] [PubMed] [Google Scholar]
  19. Sprangers M. A., de Regt E. B., Andries F., van Agt H. M., Bijl R. V., de Boer J. B., Foets M., Hoeymans N., Jacobs A. E., Kempen G. I. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol. 2000 Sep;53(9):895–907. doi: 10.1016/s0895-4356(00)00204-3. [DOI] [PubMed] [Google Scholar]
  20. Suurmeijer T. P., Waltz M., Moum T., Guillemin F., van Sonderen F. L., Briançon S., Sanderman R., van den Heuvel W. J. Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study. Arthritis Rheum. 2001 Apr;45(2):111–121. doi: 10.1002/1529-0131(200104)45:2<111::AID-ANR162>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  21. Svensson H. O., Andersson G. B. Low back pain in forty to forty-seven year old men. I. Frequency of occurrence and impact on medical services. Scand J Rehabil Med. 1982;14(2):47–53. [PubMed] [Google Scholar]
  22. Ware J. E., Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998 Nov;51(11):903–912. doi: 10.1016/s0895-4356(98)00081-x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES